Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Diabetes

Beyond Type 1 and JDRF Come Together to Drive Greater Patient Trust, Engagement & Research Participation

Beyond Type 1 has partnered with JDRF—the world’s leading nonprofit funder of Type 1 diabetes (T1D) research—to educate the T1D […]

Beyond Type 1 and JDRF Come Together to Drive Greater Patient Trust, Engagement & Research Participation
9 months ago
Share

Multicenter Preclinical (animal) Research Reports Combining Hydroxychloroquine or Chloroquine with Metformin Toxic to Mice: People Beware

Researchers from Johns Hopkins University and other prominent institutions conclude that chloroquine and hydroxychloroquine could be dangerous when combined with […]

Multicenter Preclinical (animal) Research Reports Combining Hydroxychloroquine or Chloroquine with Metformin Toxic to Mice People Beware
11 months ago
Share

University of Buffalo Investigators Contribute to the Global Trial Leading to the Approval of Fiasp®

Two clinical investigators from the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo (UB) participated in […]

University of Buffalo Investigators Contribute to the Global Trial Leading to the Approval of Fiasp®
1 year ago
Share

University of Otago Investigators Lead Global Trial to Prevent TB in People with Diabetes in Sub-Saharan Africa

New Zealand’s University of Otago researchers are participating in a larger clinical investigation—a €4.8 million international study in how to prevent tuberculosis […]

University of Otago Investigators Lead Global Trial to Prevent TB in People with Diabetes in Sub-Saharan Africa
1 year ago
Share

University of Tennessee Secures $1.98m to Pursue Possibly Breakthrough Protein Receptor to Address Type 2 Diabetes

University of Tennessee (UT) Health Science Center Memphis investigators secured $2 million to pursue their potentially breakthrough diabetes research. The […]

University of Tennessee Secures $1.98m to Pursue Possibly Breakthrough Protein Receptor to Address Type 2 Diabetes
1 year ago
Share

Promising Diabetes Investigators Receive $3.25m from ADA for Breakthrough Research

The American Diabetes Association (ADA) has awarded the Pathway to Stop Diabetes grants, totaling $3.25 million, to two promising investigators. […]

Promising Diabetes Investigators Receive $3.25m from ADA for Breakthrough Research
1 year ago
Share

Hebrew University’s Hadassah Medical Center Spin-off Developing Type 2 Diabetes Drug

Insulin resistance, the leading cause of Type 2 diabetes, is the target of a new drug under development in Israel. […]

Hebrew University’s Hadassah Medical Center Spin-off Developing Type 2 Diabetes Drug
1 year ago
Share

New AI-driven App Could Transform how People with Diabetes Improve Insulin Intake

Diabetes management app, Quin, powered by algorithmic insights and machine learning, helps users decide when and how much insulin they should […]

New AI-driven App Could Transform how People with Diabetes Improve Insulin Intake
1 year ago
Share

The University of Virginia Leads Breakthrough Study on Artificial Pancreas Leading to FDA Approval

The U.S. Food and Drug Administration (FDA) has approved an artificial pancreas system that is based on the technology from […]

The University of Virginia Leads Breakthrough Study on Artificial Pancreas Leading to FDA Approval
1 year ago
Share

Notre Dame Receives $4.6m in Hopes Investigational Drug May Halt the Need for Diabetic-based Foot Amputations

The University of Notre Dame have received a $4.6 million from the Department of Defense as a team of “Fighting […]

Notre Dame Receives $4.6m in Hopes Investigational Drug May Halt the Need for Diabetic-based Foot Amputations
1 year ago
Share

Posts navigation

Older posts
Newer posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.